Cargando...
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers
Analysis of PDL1 mRNA expression in ∼5,500 breast cancers showed PDL1 upregulation in 38% of basal tumors and 38% of inflammatory breast cancers (IBC). Upregulation, associated with signs of strong cytotoxic local immune response, was associated with a better survival in the basal or triple-negative...
Gardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839307/ https://ncbi.nlm.nih.gov/pubmed/27141340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1085148 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|